Efficacy of oral ramoplanin for inhibition of intestinal colonization by vancomycin-resistant Enterococci in mice

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 6, 2004, Pages 2144-2148

  Stiefel, Usha ^a   Pultz, Nicole J ^b   Helfand, Marion S ^b   Donskey, Curtis J ^b,c  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; DRINKING WATER; GLYCOLIPODEPSIPEPTIDE ANTIBIOTIC AGENT; RAMOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL COUNT; BACTERIAL OVERGROWTH; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CECUM; CLOSTRIDIUM DIFFICILE; COLON; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ERADICATION THERAPY; FECES CULTURE; FECES MICROFLORA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INTESTINE INFECTION; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; CANDIDA GLABRATA; CECUM; COLONY COUNT, MICROBIAL; CROSS INFECTION; DEPSIPEPTIDES; DISEASE TRANSMISSION, HORIZONTAL; ENTEROCOCCUS; FECES; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; PEPTIDES, CYCLIC; VANCOMYCIN RESISTANCE;

EID: 2542447273     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.6.2144-2148.2004     Document Type: Article

References (19)

1. Baden, L. R., I. A. Critchley, D. F. Sahm, W. So, M. Gedde, S. Porter, R. C. Moellering, and G. Eliopoulos. 2002. Molecular characterization of vancomycin-resistant enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin. J. Clin. Microbiol. 40:1160-1163.
2. Berg, R. D. 1980. Inhibition of Escherichia coli translocation from the gastrointestinal tract by normal cecal flora in gnotobiotic or antibiotic-decontaminated mice. Infect. Immun. 29:1073-1081.
3. Bonten, M. J. M., S. Slaughter, A. W. Ambergen, M. K. Hayden, J. van Voorhis, C. Nathan, and R. A. Weinstein. 1997. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci. An important infection control variable. Arch. Intern. Med. 158:1127-1132.
4. Donskey, C. J., J. A. Hanrahan, R. A. Hutton, and L. B. Rice. 1999. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J. Infect. Dis. 180:384-390.
5. Donskey, C. J., T. K. Chowdhry, M. T. Hecker, C. K. Hoyen, J. A. Hanrahan, A. M. Hujer, R. A. Hutton-Thomas, C. C. Whalen, R. A. Bonomo, and L. B. Rice. 2000. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343:1925-1932.
6. Donskey, C. J., C. K. Hoyen, S. M. Das, S. Farmer, M. Dery, and R. A. Bonomo. 2001. Effect of oral Bacillus coagulans administration on the density of vancomycin-resistant enterococci in the stool of colonized mice. Lett. Appl. Microbiol. 33:84-88.
7. Donskey, C. J., A. M. Hujer, S. M. Das, N. J. Pultz, R. A. Bonomo, and L. B. Rice. 2003. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J. Microbiol. Methods. 1807:1-8.
8. Edlund, C., L. Barkholt, B. Olsson-Liljequist, and C. E. Nord. 1997. Effect of vancomycin on intestinal flora of patients who have previously received antimicrobial therapy. Clin. Infect. Dis. 25:729-732.
9. Freter, R., H. Brickner, J. Fekete, M. M. Vickerman, and K. E. Carey. 1983. Survival and implantation of Escherichia coli in the intestinal tract. Infect. Immun. 39:686-703.
10. Hachem, R., and I. Raad. 2002. Failure of oral antimicrobial agents in eradicating gastrointestinal colonization with vancomycin-resistant enterococci. Infect. Control Hosp. Epidemiol. 23:43-44.
11. Hoyen, C. K., N. J. Pultz, D. L. Paterson, D. C. Aron, and C. J. Donskey. 2003. Effect of parenteral antibiotic administration on the establishment of intestinal colonization with extended-spectrum β-lactamase-producing Klebsiella pneumoniae in mice. Antimicrob. Agents Chemother. 47:3610-3612.
12. O'Hare, M. D., G. Ghosh, D. Felmingham, and R. N. Gruneberg. 1990. In-vitro studies with ramoplanin (MDL 62,198): a novel lipoglycopeptide antimicrobial. J. Antimicrob. Chemother. 25:217-220.
13. Ray, A. J., C. K. Hoyen, S. M. Das, T. F. Taub, E. C. Eckstein, and C. J. Donskey. 2002. Nosocomial transmission of vancomycin-resistant enterococci from surfaces. JAMA. 287:1400-1401.
14. Rolfe, R. D., S. M. Finegold. 1983. Intestinal β-lactamase activity in ampicillin-induced, Clostridium difficile-associate ileocecitis. J. Infect. Dis. 147(2): 227-235.
15. Stiefel, U., N. J. Pultz, J. Harmoinen, P. Koski, K. Lindevall, and C. J. Donskey. 2003. Oral administration of recombinant β-lactamase prevents piperacillin-induced overgrowth of nosocomial pathogens in the intestinal tract of mice. J. Infect. Dis. 188:1605-1609.
16. Vollaard, E. J., and H. A. L. Clasener. 1994. Colonization resistance. Antimicrob. Agents Chemother. 38:409-414.
17. Weinstein, M. R., H. Dedier, J. Brunton, I. Campbell, and J. M. Conly. 1999. Lack of efficacy of oral bacitracin plus doxycycline for the eradication of stool colonization with vancomycin-resistant Enterococcus faecium. Clin. Infect. Dis. 29:361-366.
18. Whitman, W. S., P. G. Pitsakis, E. DeJesus, A. J. Osborne, M. E. Levison, and C. C. Johnson. 1996. Gastrointestinal tract colonization with vancomycin-resistant Enterococcus faecium in an animal model. Antimicrob. Agents Chemother. 40:1526-1530.
19. Wong, M. T., C. A. Kauffman, H. C. Standiford, P. Linden, G. Fort, H. J. Fuchs, S. B. Porter, and R. P. Wenzel. 2001. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin. Infect. Dis. 33:1476-1482.